European Society of Cardiology

Call for Papers: Advanced Cardiac CT Application – EHJ-Case Reports We invite you to submit your work for our special issue on Advanced Cardiac Computed Tomography (CT) Application. This issue will showcase the latest advances and innovative applications in cardiac CT that are transforming patient care and influencing the future of cardiovascular medicine. Submit your research by 1 June: https://ow.ly/JJWr50Z24KP #CardiacCT #CardiovascularImaging

⏳ There’s still time to bring your discoveries into focus at #EACVI26! The abstract submission deadline has been extended, giving you additional time to share your latest breakthroughs in cardiovascular imaging with a global community of experts and peers. Submit today to: 🎤 Showcase your research within an expanded Scientific Programme designed to give your work greater visibility 💬 Exchange ideas and receive feedback from leading experts across disciplines 📖 Extend the reach of your work through publication opportunities and visibility on ESC 365 Submit your abstracts by 26 May and clinical cases by 2 June 👉 https://bit.ly/499R5FH #EACVI #cvimaging European Association of Cardiovascular Imaging - EACVI

#ImageOfTheWeek by Liabot Quentin and David Meier from CHUV Lausanne, Switzerland. What does this OCT image show? https://ow.ly/u0OU50Z24pU #cardioed

EHJ-CVP | Volume 12, Issue 3 — May 2026 Our new issue is now online — the first under the leadership of Editor-in-Chief Prof. Bianca Rocca and the new editorial board. The issue opens with an editorial from Prof. Rocca on innovation and constraints in cardiovascular pharmacotherapy, setting the tone for the journal's direction. It is followed by a PharmaPulse piece on research integrity and why it matters to all of us — a timely reminder at the start of a new editorial era. This issue covers a broad range of topics across cardiovascular pharmacotherapy: Antithrombotic therapy — lessons from andexanet alfa on targeted anticoagulant reversal and unintended consequences, and a COMPASS substudy on dual pathway inhibition in chronic coronary syndrome under the 2024 ESC criteria. Heart failure — a pre-specified Bayesian analysis of finerenone in HFmrEF/HFpEF from FINEARTS-HF, and real-world insights on SGLT2 inhibitors in heart failure with tricuspid regurgitation from the SHEBAHEART registry. SGLT2 inhibitors — a multidisciplinary expert perspective on implementing SGLT2 inhibitors in cardiovascular-kidney-metabolic syndrome. And the annual review Cardiovascular Pharmacotherapy in 2025, a comprehensive overview of the field. All articles are Open Access. https://lnkd.in/dTQVdFRE #EHJCVP #Cardiology #ClinicalPharmacology #Pharmacotherapy #CardiovascularMedicine #OpenAccess

EU NextGen project advances personalised cardiology by integrating genomic and clinical data into AI models 👉 https://lnkd.in/dJ5WPKaw Dimitra Antonakaki Steffen Petersen

The 2nd episode of ESC CardioTalk: Cardio-Oncology is now live! 👉 How to Monitor the Heart During HER2+ Breast Cancer Therapy 🎙️ Host: Massimiliano Camilli 🇮🇹 🎤 Speaker: Jennifer Liu 🇺🇸 A practical discussion on cardiovascular monitoring during HER2-targeted therapy, including: 🩺 Echocardiography 🧪 Cardiac biomarkers ⚠️ Early detection of cardiotoxicity 🤝 Multidisciplinary cardio-oncology care A must-listen for everyone involved in breast cancer and cardio-oncology care 🚀 🎧 Listen now: https://lnkd.in/eXAURmrC Massimiliano Camilli Mariana Mirabel Novi Yanti Sari Pedro Moliner Borja Teresa López Fernández Trecy Gonçalves Maria Clara Llamedo Jutta Bergler-Klein Sebastian Szmit Giuseppina Novo Peter van der Meer Alexandra Pons Riverola Hasnaa Belghiti ESC Social Media Team

ESC Chat achieves CE Class I certification This certification under the EU Medical Device Regulation recognises ESC Chat as a trusted resource for healthcare professionals, providing easy access to ESC Guidelines. Its responses are grounded in ESC guidance, with clear structure and referenced sources to support everyday practice. Download the app today https://ow.ly/2UiP50Z24h4 #ESCGuidelines #Cardiology #DigitalHealth #AIinMedicine

Read Dr. Levent Pay's comment on the Cardiovascular Research article "Targeting the ALCAT1 enzyme for the treatment of pressure-overload hypertrophy". The full study provides further insight into mitochondrial lipid remodeling and emerging therapeutic opportunities in pressure-overload induced heart failure https://ow.ly/OcpO50Z248i #CardiovascularResearch #HeartFailureResearch